Emerald Mutual Fund Advisers Trust’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-82,212	Closed	-$3.78M	–	273
2017 Q2	$3.78M	Sell	82,212 -140,400	-63%	-$6.81M	0.16%	152
2017 Q1	$9.64M	Hold	222,612	–	–	0.44%	78
2016 Q4	$8.62M	Sell	222,612 -62,178	-22%	-$2.81M	0.41%	88
2016 Q3	$14.4M	Buy	284,790 +19,399	+7%	+$966K	0.73%	50
2016 Q2	$12.1M	Sell	265,391 -31,392	-11%	-$1.45M	0.68%	53
2016 Q1	$11.7M	Buy	296,783 +645	+0.2%	+$25.6K	0.66%	60
2015 Q4	$16.8M	Buy	296,138 +27,000	+10%	+$1.37M	0.88%	34
2015 Q3	$10.7M	Sell	269,138 -39,540	-13%	-$1.91M	0.7%	53
2015 Q2	$14.7M	Sell	308,678 -38,949	-11%	-$1.65M	1.14%	21
2015 Q1	$13.1M	Sell	347,627 -107,230	-24%	-$3.84M	1.08%	25
2014 Q4	$10.2M	Buy	454,857 +150,948	+50%	+$2.86M	0.88%	43
2014 Q3	$4.76M	Buy	303,909 +44,546	+17%	+$666K	0.46%	80
2014 Q2	$3.85M	Buy	259,363 +20,803	+9%	+$294K	0.35%	97
2014 Q1	$3.84M	Buy	+238,560	New	+$4.08M	0.37%	93